Literature DB >> 18513716

Commentary: Dopaminergic dysfunction in DYT1 dystonia.

Thomas Wichmann1.   

Abstract

A three-base-pair deletion in the torsinA gene leads to generalized torsion dystonia (DYT1) in humans, an often devastating movement disorder in which voluntary movements are disrupted by sustained muscle spasms and abnormal limb posturing. In a recent issue of Experimental Neurology, Zhao et al. (2008) have provided a thorough behavioral, anatomic, and biochemical characterization of a mouse line that over-expresses human mutant torsinA, with particular emphasis on the possible role of dopaminergic dysfunction in these animals. This commentary provides an overview of the clinical and genetic features of the human disease and of the available transgenic mouse models for DYT1 dystonia, and discusses the evidence favoring the role of dopamine in the clinical manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513716      PMCID: PMC4305330          DOI: 10.1016/j.expneurol.2008.04.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  89 in total

Review 1.  Dystonia genotypes, phenotypes, and classification.

Authors:  Susan B Bressman
Journal:  Adv Neurol       Date:  2004

2.  Dopamine transmission in DYT1 dystonia.

Authors:  Sarah J Augood; Z Hollingsworth; David S Albers; Lichuan Yang; Joanne Leung; Xandra O Breakefield; David G Standaert
Journal:  Adv Neurol       Date:  2004

3.  A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study.

Authors:  N Sharma; J Hewett; L J Ozelius; V Ramesh; P J McLean; X O Breakefield; B T Hyman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Bromocriptine for levodopa-induced end-of-dose dystonia.

Authors:  M Hallett
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

5.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.

Authors:  S D Tabbal; J W Mink; J A V Antenor; J L Carl; S M Moerlein; J S Perlmutter
Journal:  Neuroscience       Date:  2006-06-12       Impact factor: 3.590

6.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

7.  Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons.

Authors:  S R Goldstein; R R Matsumoto; T L Thompson; R L Patrick; W D Bowen; J M Walker
Journal:  Synapse       Date:  1989       Impact factor: 2.562

8.  Pramipexole-induced antecollis in Parkinson's disease.

Authors:  Masahiko Suzuki; Toshiaki Hirai; Yasuhiko Ito; Tsuyoshi Sakamoto; Hisayoshi Oka; Akira Kurita; Kiyoharu Inoue
Journal:  J Neurol Sci       Date:  2007-09-10       Impact factor: 3.181

9.  Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation.

Authors:  Antonino Uncini; Maria Vittoria De Angelis; Patrizia Di Fulvio; Michele Ragno; Grazia Annesi; Alessandro Filla; Liborio Stuppia; Domenico Gambi
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338

10.  Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

View more
  32 in total

1.  RNA interference-mediated inhibition of wild-type Torsin A expression increases apoptosis caused by oxidative stress in cultured cells.

Authors:  Xue-Ping Chen; Xiao-Hui Hu; Shu-Hui Wu; Yang-Wei Zhang; Bo Xiao; Hui-Fang Shang
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

Review 2.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

3.  Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia.

Authors:  Chang-Hyun Song; Doug Bernhard; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

4.  Deep-Brain Stimulation for Basal Ganglia Disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Basal Ganglia       Date:  2011-07-01

Review 5.  Pathological basal ganglia activity in movement disorders.

Authors:  T Wichmann; J O Dostrovsky
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

6.  Dysregulation of striatal dopamine release in a mouse model of dystonia.

Authors:  Li Bao; Jyoti C Patel; Ruth H Walker; Pullanipally Shashidharan; Margaret E Rice
Journal:  J Neurochem       Date:  2010-07-27       Impact factor: 5.372

Review 7.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

8.  Mutant torsinA interacts with tyrosine hydroxylase in cultured cells.

Authors:  C A O'Farrell; K L Martin; M Hutton; M B Delatycki; M R Cookson; P J Lockhart
Journal:  Neuroscience       Date:  2009-09-15       Impact factor: 3.590

9.  Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia.

Authors:  Chang-Hyun Song; Douglas Bernhard; Caroline Bolarinwa; Ellen J Hess; Yoland Smith; H A Jinnah
Journal:  Neurobiol Dis       Date:  2013-01-19       Impact factor: 5.996

10.  A new knock-in mouse model of l-DOPA-responsive dystonia.

Authors:  Samuel J Rose; Xin Y Yu; Ann K Heinzer; Porter Harrast; Xueliang Fan; Robert S Raike; Valerie B Thompson; Jean-Francois Pare; David Weinshenker; Yoland Smith; Hyder A Jinnah; Ellen J Hess
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.